Agilent to appeal patent office decision on CRISPR gRNA patents
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Mindset disagrees with and denies the allegations set forth from Reunion.
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic, and prostate cancer
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Natco Chlorantraniliprole (CTPR) Process does not infringe FMC's Indian Patent 298645.
Both products are broad-spectrum, foliar insecticides used across wide range of crops
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
ELCYS is the only FDA-approved cysteine hydrochloride injection on the market for use as an additive to amino acid solutions
All claims made by Seagen regarding Daiichi Sankyo antibody drug conjugates are denied
Subscribe To Our Newsletter & Stay Updated